108 results
S-3ASR
PRTA
Prothena Corporation plc
22 Feb 24
Automatic shelf registration
5:29pm
of disposition or “excess distribution” cannot be offset by any net operating losses for such years, and gains (but not losses) realized on the sale of our
8-K
EX-99.1
PRTA
Prothena Corporation plc
2 Nov 23
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights
4:09pm
due to higher clinical trial expenses, higher personnel related expenses and higher consulting offset in part by lower manufacturing expenses. R&D
424B5
d34k28e6nu
16 Dec 22
Prospectus supplement for primary offering
4:31pm
424B5
udm5q
13 Dec 22
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
aell59dlm0f sugshk9l
3 Nov 22
Prothena Reports Third Quarter 2022 Financial Results and Business Highlights
4:24pm
8-K
EX-99.1
z0huyyxz
8 Aug 22
Prothena Reports Second Quarter 2022 Financial Results and Business Highlights
4:27pm
8-K
EX-99.1
eag1d
5 May 22
Prothena Reports First Quarter 2022 Financial Results and Business Highlights
12:00am
8-K
EX-99.1
6w8x1iai39h
17 Feb 22
Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights
4:07pm
424B5
4wag hjigvx
23 Dec 21
Prospectus supplement for primary offering
5:16pm